From API sourcing to commercial launch, MassMed manages the complete pharmaceutical manufacturing lifecycle through a rigorously audited global CDMO network—so every product reaches the market on time, on spec, and fully compliant.
We don't just manufacture—we own every step from selection to shipment, ensuring nothing slips between the cracks.
Tablets, capsules, injections, syrups, and beyond—manufactured under strict GMP guidelines across certified facilities.
We don't rely on a single manufacturer. Our network spans audited CDMOs across India, Europe, and Asia—each selected based on regulatory standing, product expertise, and supply reliability.
This distributed model lets us match every product to the optimal facility—balancing cost, capacity, and the exact regulatory approvals required for your target market.
We match product type, batch size, and regulatory requirement to the most qualified facility in our network—every single time.
Multi-source capability means your supply chain stays resilient even during global disruptions or facility issues.
We conduct or coordinate thorough facility audits—reviewing GMP systems, batch documentation, personnel, and inspection readiness.
From pilot batches to commercial scale, with market-appropriate packaging, serialization, and labelling—all in one place.
A structured, transparent pathway from initial inquiry through to your first commercial shipment.
Technical & legal agreement with manufacturing facility
GMP audit, QMS review, and inspection readiness check
CTD/eCTD/ACTD preparation by our regulatory team
Sample generation, stability studies, and market-ready packaging
Commercial manufacturing, release, and logistics management
A broad range of manufacturing and development capabilities, all under one coordinated partnership.
Granulation, compression, coating, and encapsulation at scale with full batch documentation.
Aseptic fill-finish in ISO-classified environments for ampoules, vials, and pre-filled syringes.
Syrups, suspensions, ointments, creams, and gel formulations with validated stability data.
Standardized herbal extracts and nutraceutical blends with scientific validation and dossier support.
Formulation development, API sourcing, tech transfer to CDMOs, and scale-up support for niche molecules.
Diagnostic kits, consumables, and hospital essentials sourced from ISO 13485-certified manufacturers.
Our QA model goes beyond paperwork. We're physically present at critical stages to ensure what you receive is exactly what you specified.
Physical inspection and COA validation before every commercial shipment leaves the facility.
Full BMR, BPR, and stability data review to ensure every batch is audit-ready and authority-compliant.
We handle market complaints at source—minimizing recalls, regulatory actions, and reputational risk.
Post-market surveillance and adverse event reporting assistance to maintain registration validity.
Tell us your product, target market, and timeline—we'll handle the rest. From CDMO selection to your first commercial shipment.
2016-2025, Massmed Private Limited•Crafted with ♥ in India